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Under certain culture conditions, Miracil (35 ,ug/ml) halts the growth of unin-
fected Escherichia coli. Cellular ribonucleic acid (RNA) synthesis is almost com-
pletely suppressed, whereas deoxyribonucleic acid and protein synthesis are in-
hibited to a lesser extent. When the drug is added to host bacteria prior to infection
with bacteriophage MS2, the phage adsorb to the cells, but penetration of the viral
RNA is inhibited. Penetration may be achieved without further viral development
by infection in the presence of chloramphenicol. If the bacteria are infected with
MS2 in the presence of chloramphenicol, subsequently washed to remove the
chloramphenicol, and then treated with Miracil at any time between 0 and 20 min
postinfection, a second viral function is inhibited and the yield of progeny phage is
reduced. Addition of the drug after 20 min postinfection does not inhibit the infec-
tion process. When Miracil is present from early times in infection, only a limited
synthesis of both double- and single-stranded virus-specific RNA is observed. The
viral RNA species thus produced do not appear to differ from those made in the
absence of the drug. A comparison of the activities of the viral RNA synthetase
produced during the course of infection in the presence and in the absence of Miracil
suggests that a possible cause of the inhibition is the synthesis of an unstable en-
zyme in the presence of the drug.
During infection of Escherichia coli with
most ribonucleic acid (RNA) bacteriophages, a
high rate of normal cellular macromolecular
synthesis persists and it is difficult to label
phage-specific RNA and protein species selec-
tively with radioisotopes. Actinomycin, rifampin,
and ultraviolet irradiation of the bacterial cells
have been used as methods to inhibit host RNA
synthesis. However, viral replication may be
abnormal after any of these treatments since
phage yield is markedly reduced, and some RNA
species not found in untreated infected cells
are observed (5, 7, 9, 14).
This report describes a new method, using the
drug Miracil D, for suppressing E. coli-directed
RNA and protein synthesis during infection
by the RNA bacteriophage MS2. Miracil acts
in a manner similar to actinomycin, inhibiting
deoxyribonucleic acid (DNA)-dependent RNA
synthesis by complexing with the DNA (21).
In contrast to actinomycin, however, the host
cells are permeable to Miracil and need not be
I Present address: Laboratory of Molecular Biology, Uni-
versity of Wisconsin, Madison 53706.
sensitized to drug action by preliminary treat-
ment with tris(hydroxymethyl)aminomethane
(Tris)-ethylenediaminetetraacetic acid (EDTA)
(11). This not only simplifies experimental
manipulations but eliminates artifacts resulting
from the Tris-EDTA treatment, which is
known to affect cellular metabolism extensively
under certain conditions (12, 15). The experi-
ments discussed here deal with selective labeling
of viral RNA. Evidence for selective labeling of
viral proteins in the presence of Miracil has been
presented elsewhere (3).
MATERIALS AND METHODS
Chemicals. Thymidine-methyl-3H, uracil-6-3H, and
l-leucine-4,5-3H were purchased from Schwartz
BioResearch, Inc. 32p, carrier-free, was obtained
from Mallinckrodt Nuclear. Chloramphenicol was a
gift from Parke, Davis & Co. Miracil D (lucan-
thone HCI) was the gift of Burroughs Wellcome and
Co. through the courtesy of George Hitchings.
Miracil stock solutions at 1 mg/ml were made up
fresh in distilled water every 1 or 2 days because the
drug loses its effectiveness when kept in solution
over longer periods of time.
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Media. MS broth was the same as that described
by Pfeifer et al. (17), except the CaCl2 concentration
was reduced to 10-4 M. The pH of this medium is 6.8.
TPG-minimal contained NaCl 0.5 g; KCl, 8.0 g;
NH4Cl, 1.1 g; Trizma base, 12.1 g; KH2PO4, 0.8 g;
sodium pyruvate, 0.8 g; 1.0 ml of 20%o MgC12'
6H20; and 1.0 ml of 0.16 M Na2SO4 per liter of dis-
tilled water. The pH was adjusted to 7.4. After auto-
claving, 20 ml of 10% glucose and 1.0 ml of 0.1 M
CaCl2 were added.
TPG-c was TPG-minimal plus 3.0 g of vitamin-
free Casamino Acids (Difco) per liter.
TPA (low phosphate) was TPG-minimal with the
KH2PO4 concentration reduced to 0.046 g/liter and
the addition of 2.7 g of amino acid mixture per liter
(special 20 natural I-amino acid mixture, Nutritional
Biochemicals Corporation).
Although the CaCl2 concentration in all these
media was reduced to 10-4 M, phage production and
the extent and kinetics of infective center formation
were the same as in the higher Ca2+ concentration
(2 X 10-3 M) usually used for RNA phage infection.
Biological assays. All dilutions of phage and cells
were made through MS broth from which the glu-
cose, CaCl2, and thiamine had been omitted. Plaque
assays and viable counts were done by using the agar
layer technique. E. coli C3000 grown to 108 to 2 X
108 cells/ml in MS broth was used as plating bac-
teria.
Infective centers were defined as infected cell
complexes and did not include free phage particles.
They were measured by adding 0.1 mnl of an infected
culture to 0.9 ml of a 1: 300 dilution of MS2 anti-
serum (K = 1,040) at 4 C. After 5 min in antiserum,
the infected cells were diluted and plated immedi-
ately.
To titer intracellular plus extracellular phage,
0.1 ml of an infected culture was diluted into 0.8 ml
of 0.033 M Tris, pH 8. Then 0.1 ml of lysozyme (4
mg/ml in 0.25 M Tris, pH 8.1) and 0.2 ml of EDTA
(4% in distilled water) were added and the samples
were incubated for 10 min at 0 C. The cells were
lysed by the addition of 0.8 ml of 0.1% sodium do-
decyl sulfate (SDS; Matheson, Coleman, and Bell),
and the phage were titered.
Infectivity assays of MS2 RNA were performed
with the E. coli spheroplast system of Strauss and
Sinsheimer (18).
Chloramphenicol synchronization of infection. The
synchronization procedure is an adaptation of that
used by Kelly et al. (10). Uninfected cells were incu-
bated for 5 min in chloramphenicol, 25 pg/ml, and
the culture was infected with the desired multiplicity
of MS2. After an additional 5 min of incubation,
the cells were collected by filtration on a cellulose
nitrate filter (Millipore HAWP, 0.45 pAm pore size),
washed with two volumes of media to remove the
chloramphenicol, and resuspended in growth medium
warmed to 37 C. This was taken as time zero. The
phage RNA penetrates in the presence of chloram-
phenicol, but the infection proceeds no further until
the drug is removed since the viral RNA synthetase is
not synthesized in its presence.
Radioactivity measurements. Incorporation of 3H-
uracil and 3H-leucine into cold and hot trichloro-
acetic acid-insoluble material, respectively, was
measured by precipitating 0.5-ml samples of labeled
cultures with 2.0 ml of 7% trichloroacetic acid. In-
corporation of 3H-thymidine into cold acid-insoluble
material was also measured by precipitation of
labeled samples with 7% trichloroacetic acid, ex-
cept that the samples were first incubated in 0.5 N
KOH at 37 C for 12 hr. Denatured calf thymus DNA
(100 pg) was added as carrier to all radioactive sam-
ples.
Labeled RNA was detected on sucrose gradients
by the following method. Each gradient fraction
was diluted with 1.0 ml of a buffer containing 0.1
M Tris (pH 7.4), 0.01 M MgCl2, and 0.1 M NaCl
(TMS buffer). Cart ier was added, and the samples
were precipitated with cold trichloroacetic acid as
above. If the ribonuclease resistance of the RNA in
each fraction was to be determined, one half of the
sample was precipitated and counted; the other
half was incubated at 37 C with 25 pAg of ribonuclease
per ml (Bovine Pancreas, Type I-A, Sigma Chemical
Co.) for 30 min to digest any single-stranded RNA
prior to precipitation and counting.
Acid precipitates were collected on Whatman
glass filters. Dried filters were placed in scintillation
fluid which contained 42 ml of Liquifluor (New
England Nuclear Corp.) per liter of toluene and
counted in a Beckman scintillation counter.
Phenol extraction and sedimentation of RNA.
All RNA extraction procedures were carried out at
0 to 4 C. Cells were chilled, collected by centrifuga-
tion, and resuspended in 1.0 ml of 0.1 M Tris, pH
7.4. After the addition of 0.2 ml of 10% SDS, the
samples were vortexed vigorously and frozen and
thawed once. This treatment was sufficient to lyse
the cells.
The lysate was extracted twice with equal volumes
of water-saturated phenol and once with ether, and
the RNA was precipitated by the addition of sodium
acetate to 0.3 M and three volumes of 100% ethanol.
After 8 to 10 hr at -20 C, the precipitate was col-
lected by centrifugation and resuspended either in
TMS buffer, if the sample was to be assayed for ribo-
nuclease-resistant RNA, or in 0.1 M Tris, pH 7.4,
if the RNA was to be analyzed by sucrose gradient
sedimentation.
Five milliliters of 5 to 20% (w/v) linear sucrose
gradients in 0.1 M Tris, pH 7.4, were poured at room
temperature and chilled to 4 C. RNA samples (0.1
ml) in the same buffer were layered on the gradients.
The length and speed of centrifugation are desig-
nated in the figure legends for each experiment. All
sucrose gradients were collected dropwise from the
bottom of the centrifuge tube.
Preparation of 32P-labeled MS2. 32P-labeled MS2
virus was prepared by the method of Godson and
Sinsheimer (8).
Viral RNA synthetase assay. Cells which were to be
assayed for viral RNA synthetase were disrupted by
the Brij lysis method described by Godson and Sins-
heimer (8), and the crude lysate was used as the en-
zyme source. Since the lysate contains 50 pug of
deoxyribonuclease per ml, it is highly unlikely that
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any activity in the assay is due to DNA-dependent
RNA polymerase. Protein concentration was deter-
mined by the Folin procedure (13).
The reaction mixture contained in 0.25 ml: Tris
(pH 7.4), 20 jAmoles; MgSO4, 3 ,Amoles; adenosine
triphosphate, uridine triphosphate, and guanosine
triphosphate, 0.2 MAmole each; cytidine triphosphate
(CTP), 0.05 ,Amole; 3H-CTP, 0.5 IuCi, 4 X 10-4
,Amole (Schwartz BioResearch, Inc.). After incuba-
tion at 37 C for 6 min, the reaction was stopped by
the addition of 2.0 ml of 7% trichloroacetic acid,
carrier was added, and the precipitate was collected
on glass filters. Under these conditions, incorporation
of 3H-CTP into acid-precipitable material was linear
with time for approximately 8 to 10 min. Negligible
incorporation of 3H-CTP was observed when crude
lysates of uninfected cells were assayed.
RESULTS
Growth and metabolism of uninfected kacteria
in Miracil. The effect of Miracil D on the growth
and metabolism of E. coli varies from strain to
strain as well as in the same bacterial strain
grown in different media (20). Under different
culture conditions, the same drug concentration
may lyse the cells, halt cell growth without
causing lysis, or have no apparent effect on the
cells at all. Before examining the effect of Miracil
on the MS2 infection process, we tested its
action on E. coli MRE 600, a ribonuclease 17
strain (2), the strain to be used as host in sub-
sequent MS2 experiments. Two differently
supplemented minimal media routinely used for
MS2 growth were used. In TPG-c with 15 ,ug of
Miracil/ml, bacterial growth continues but is
markedly inhibited. In the same medium with
25 jig/ml, the cells cease to grow after one genera-
tion, whereas in 35 ,ug/ml, no growth occurs
after addition of the drug. In the second me-
dium, TPA, Miracil at the same concentrations
has very little effect on cell growth. When cul-
tures grown in a glucose-salts minimal medium,
TPG-minimal, or a complex medium, MS
broth, were treated with Miracil, the results were
the same as those observed in TPG-c. In both
cases 35 ,ug/ml halted cell growth without causing
lysis.
In each of these experiments, the pH of the
medium was as described above. Similar results
were obtained when the pH of each medium
was varied from 6.5 to 7.8. Since small differences
in pH might affect the solubility and hence the
activity of Miracil, the pH of each medium was
checked again immediately prior to addition of
the drug to be certain no change had occurred
during growth of the cells. We had found that
the sensitivity of the cells to Miracil was in-
hibited by high Ca2+ concentrations (2 X 10-3
M); therefore all media contained only 10-4
M Ca2+ (see above).
In the presence of Miracil, incorporation of
3H-thymidine into DNA in cultures grown in
TPG-c is normal for the first 5 min and then con-
tinues at a reduced rate (Fig. la). At 35 jig/ml,
the rate of incorporation decreases steadily for
about one generation time, and after 40 min
virtually no uptake occurs. Total synthesis in
40 min is approximately 10% of that in the un-
treated culture.
The inhibition of RNA and protein synthesis
is more rapid (Fig. lb, c). The effect on both
uracil and leucine uptake is evident after 5 min.
By this time, total 3H-uracil incorporation in
35 ,ug of Miracil/ml is only 12% of that in the
untreated culture. (Experiments not shown
have demonstrated that, after only 2 min in
Miracil at 35 ,ug/ml, the final suppressed rate of
RNA synthesis, about 5% of that in an un-
treated culture, is achieved.) Incorporation of
3H-leucine is also reduced, but at 35 jAg/ml it is
not as depressed as 3H-uracil incorporation.
Miracil at 15 and 25 ,ug/ml also inhibits bac-
terial macromolecular synthesis but to a lesser
extent than at 35 jig/ml. The degree of inhibition
with a given Miracil concentration is quite
reproducible from one experiment to another.
Effect of Miracil on the MS2 infection process.
For Miracil to be useful in studies of MS2 infec-
tion, it is necessary to use drug doses which re-
duce host RNA and protein synthesis to low
levels but which do not severely disrupt the in-
fection process. Figure 2 shows the effect of in-
creasing Miracil concentrations on infective
center formation and progeny phage yield when
the drug is added 1 min after the addition of
phage. Infective centers are slightly reduced at
lower concentrations but drop off sharply be-
tween 30 and 40 jig/ml. This effect at higher con-
centrations has been observed repeatedly. The
effect on phage yield is even more pronounced
than the decline in the number of infective centers.
The average burst size per infective center de-
creases exponentially with increasing drug con-
centration above 5 ,ug/ml.
We first studied the effect of Miracil on the
early steps of infection-adsorption and penetra-
tion. RNA phage will adsorb to nonmetabolizing
cells, either at 0 C or in the presence of metabolic
inhibitors, but for the RNA to penetrate, cellular
metabolic activity is required (4). An E. coli
culture was divided into two equal portions,
and one half was treated with Miracil, 40 jig/ml,
for 3 min. Both cultures were chilled rapidly to
0 C, 32P-labeled MS2 was added to each at a
multiplicity of one, and at various times samples
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FIG. 2. Inhibition ofRNA phage growth by increas-
ing concentrations of Miracil. E. coli cells were grown
to 2 X 108/ml in TPG-c and infected with MS2 at a
multiplicity of 5. The culture was divided into eight
equal portions, and Miracil, at the indicated concen-
trations, was added I min after infection. At 6 min
postinfection, infective centers were measured, and,
after incubating the cultures in Miracil for 70 min,
intra- plus extracellular phage were titered. The
values are expressed as per cent of the control culture
which received no Miracil. 0, Infective centers;
*, intra- plus extracellular phage.
o0 TIfi were removed, and the cells were pelleted and0 l0 20 30 40 counted. The amount of radioactivity in the
pellets from the treated and untreated cultures
6 (c) was the same, indicating that the amount ofphage adsorption was equivalent in the two
5 cultures. If the cells were blended prior to pellet-
ing to remove the pili, and thus the adsorbed
4 phage, almost no radioactivity was found in
'IO the cell pellet. To assay for penetration, we
3
-_ chilled Miracil-treated and untreated cultures,
as in the preceding experiment, and allowed2 > 9 . 2P-labeled MS2 to adsorb at 0 C for lO min.
l_/++--+- The cultures were then warmed rapidly to 37 C,
Ig~+ e_samples were removed at various times and
0 l blended to remove adsorbed but uninjected
0 10 20 30 40 phage, and the cells were pelleted and counted.
TIME (min) By 10 min postinfection, only 10%7 as much
radioactive RNA had penetrated the Miracil-
FIG. 1. Inhibition of bacterial DNA (a), RNA (b),
and protein (c) synthesis by Miracil. A culture of E.
coli MRE 600 was grown to 2 X 108 cells/ml in
TPG-c (containing 4 iig of thymidine/ml and 5 ,ug of
uracil/ml) and split into three portions. 3H-thymidine
was added to the first to a concentration of I IACi/ml,
3H-uracil was added to the second to a concentration
of 0.5 ,uCi/ml, and 3H-leucine was added to the third
to a concentration of 1.0 IACi/ml. Each of these sub-
cultures was divided immediately into four equal por-
tions containing no Miracil (0), 15 ,ug of Miracil/
ml, (0), 25 4g of Miracil/ml, (+), and 35 4ig of
Miracil/ml, (A).
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treated cells as the untreated cells. The same
results were obtained if the phage were not pre-
adsorbed at 0 C. These results indicate that MS2
adsorbs in the presence of Miracil, but only a
small proportion of the viral RNA penetrates.
Apparently, some metabolic activity required for
penetration is disrupted by Miracil.
Viral RNA penetration is asynchronous and is
not complete until 8 or 9 min postinfection (R.
B. Kelly, Ph.D. thesis, California Institute of
Technology, Pasadena, 1967). So that pene-
tration could be completed and the effects of
Miracil on subsequent steps of infection ex-
amined, bacteria were infected synchronously in
chloramphenicol (see above), and Miracil was
added subsequent to the removal of the chloram-
phenicol. Figure 3 shows the inhibitory effect
of Miracil on phage yield in chloramphenicol-
synchronized cells when the drug is added at
succeeding times during infection. Maximum
inhibition occurs when Miracil is added during
100
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70 H
60 _
50 K
40K
30 _
20 _
10
0 5 10 5 20 25
TIME OF MIRACIL ADDITION (mmn)
FIG. 3. Time course of Miracil inhibition. E. coli
cells were grown to 2 X 108/ml in TPG-c. Chloram-
phenicol was added to synchronize the infection as
described in the text, and the culture was infected with
MS2 at a multiplicity of 10. Five minutes after the
addition of MS2, the chloramphenicol was removed
and the cells were resuspended in TPG-c warmed to
37 C. This was taken as time zero. At the indicated
times, Miracil, 35 jig/ml, was added to samples of
the culture. All samples were incubated to 70 min
postinfection, and the intra- plus extracellular phage
were titered. Phage yield is expressed as per cent of
the titer at 70 min in a culture which had not been
treated with Miracil.
the first few minutes of infection. The infection
becomes progressively less sensitive to the drug,
and, after 20 min, phage yield is unaffected by
the presence of Miracil. Progeny phage are
just beginning to appear at this time; therefore,
viral maturation and assembly apparently are
unaffected by the drug. In addition, most of the
coat and maturation protein necessary for
phage production is synthesized later than 20
min of infection (19); therefore, viral protein
synthesis is probably also insensitive to Miracil
action. Whatever function is inhibited by the
drug is either completed or no longer essential
for phage production by this time.
The inhibitory effect on phage yield which is
observed when Miracil is added early in infec-
tion is partially reversible. A culture was in-
fected in the presence of chloramphenicol,
washed, and resuspended. One minute later,
Miracil (35 Ag/ml) was added (exactly as for the
first time point in the preceding experiment),
and at short intervals up to 20 min after addition
of Miracil, samples of the culture were diluted
10,000-fold to reduce the drug concentration,
incubated for 2 hr, and titered. In the sample
which was diluted after exposure to Miracil for 1
min, the number of progeny phage produced
was normal. This short incubation in Miracil
is not completely without effect, however, since
the lag period before the appearance of progeny
phage is longer than in the control culture which
was diluted just prior to the addition of Miracil.
As incubation times in Miracil are increased to
longer than 1 min, the phage yield begins to
decrease; however, even after the infection has
proceeded for 20 min in the presence of Miracil,
partial recovery is observed since the phage
titer in the culture which was diluted out of
Miracil after 20 min was five times that of a
culture which remained in Miracil during the
entire 2-hr incubation period.
In the experiment above, the decreased phage
yield after exposure of infected cells to Miracil
for 10 min or less is due to a drop in the number
of infected cells, whereas the average burst
size per infective center remains constant. After
longer incubation periods in Miracil, the average
burst size also begins to decline.
A parallel experiment was done to determine
whether the effect of Miracil on the colony-
forming ability of uninfected cells was also
reversible. Cells were incubated for the same
intervals in Miracil at 35 ,ug/ml and then were
diluted and plated immediately. There is a
striking similarity between the proportion of
cells which are still able to form colonies and
the extent to which infection can proceed. This
relationship may simply be fortuitous. However,
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it may be an indication that only those cells
which can still divide and form colonies after
treatment with Miracil are able to provide some
function which is required for MS2 infection.
Phage RNA synthesis. Synthesis of virus-
specific RNA in Miracil-treated culture was
studied in an attempt to determine what step
in the replication cycle is blocked by the drug
once penetration is complete, and to see whether
the virus-specific RNA species which continue
to be synthesized are altered in the presence of
the drug. Miracil was added at 3 min post-
infection to one half of a culture infected with
32P-labeled MS2, and the fate of the infecting
viral RNA was followed to see if parental RF
was formed. Samples from the culture with and
without Miracil were removed at 3-min intervals
until 15 min postinfection, and the per cent of
parental RNA in ribonuclease-resistant form
was determined in each. Although the infection
was not synchronized in this experiment, only
the fate of the RNA which has penetrated the
cells is observed since the culture was blended to
remove uneclipsed phage particles prior to RNA
extraction. In the presence of the drug, conver-
sion of labeled RNA to ribonuclease-resistant
form ceases after a few minutes, but that in the
untreated culture continues. By 15 min post-
infection, the total percentage of 32P-labeled
ribonuclease-resistant material formed in the
Miracil-treated culture is less than half of that
in the infected culture with no Miracil.
To see whether alteration or degradation of the
infecting RNA strand in the presence of Miracil
might be responsible for the decreased parental
RF formation, the RNA from the treated and
untreated 12-min samples in the above experi-
ment was analyzed by sucrose gradient sedimen-
tation (Fig. 4). The RNA from the culture with-
out Miracil contains about twice as much ribo-
nuclease-resistant material sedimenting in the
viral replicative intermediate region from 16 to
25S as the Miracil-treated culture, but in all
other respects the sedimentation patterns of the
two RNA samples are very similar. Breakdown
of viral RNA into slower sedimenting species
and possibly limited incorporation of 32p into
host RNA have occurred in both cultures; how-
ever, degradation of parental RNA is not unusual
this late in infection, and the viral RNA from
the Miracil-treated culture is not more extensively
degraded than that from the untreated culture.
If the drug causes minor alterations in the infect-
ing RNA or binds to the RNA to interfere with
its conversion to RF, the sedimentation proper-
ties of the parental RNA would not be expected
to change markedly.
400 - * U,
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c 100 _
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FIG. 4. Sedimentation pattern of 32P-labeled viral
RNA isolated from Miracil-treated cells. The RNA
samples from the 12-min time point in the experiment
discussed in the text were sedimented on 5-ml 5 to
20%o sucrose gradients; a, untreated; b, Miracil-
treated. Centrifugation was at 180,000 X g for 4
hr in an SW65 rotor at 4 C. Each gradient fraction
was split; one half was precipitated directly and the
other half was assayed for ribonuclease resistance
before precipitation and counting. (The direction of
sedimentation was from right to left.) 0, Total 32p
counts per minute; 0, ribonuclease-resistant 32p
counits per minute.
The next experiment was designed to deter-
mine whether synthesis of both viral and com-
plementary strands, represented by infective
and ribonuclease-resistant RNA, respectively,
could continue in the presence of Miracil. Sam-
ples were removed from an 3H-uracil-labeled,
infected culture at intervals during infection.
One half was assayed for infective RNA and
ribonuclease-resistant material; the other half
was treated with Miracil, incubated to 40 min
postinfection, and then assayed for infectivity
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and ribonuclease resistance to see whether the
number of viral and complementary strands had
increased in the presence of the drug. Table 1
shows the results for infective RNA. Clearly,
viral strand synthesis continues in Miracil.
When the drug is added early in infection, only a
limited increase is seen, but between 20 and 25
min postinfection, RNA synthesis escapes from
the inhibitory effect and a normal amount of
infective RNA is made. Table 2 shows that the
amount of ribonuclease-resistant RNA also
increases after the addition of Miracil; thus,
complementary strand synthesis must also
continue in the presence of the drug.
To see whether any of the virus-specific RNA
species synthesized in the presence of Miracil
differed from those found in its absence, the
following experiment was done. An infected
culture was divided at 8 min postinfection, and
one half was treated with Miracil, 35 ug/ml.
(Addition of Miracil at 8 min in this and the
following experiment allowed penetration to be
TABLE 1. Effect of Miracil on synthesis of infective
viral RNAa
Relative infectivity
Relative at 40 min with
th infectivity at tc Miracil present
(%) from t to 40 minc
(%)
4 0.02 2.3
8 0.07 0.54
12 0.43 11.0
16 3.3 13.1
20 8.3 17.4
25 25.8 98.0
40 100 100
a E. coli cells were grown to 2 X 108/ml in TPG-c
plus uracil, 5 ,ug/ml, and infected with MS2 at a
multiplicity of 5. 3H-uracil was added to a con-
centration of 0.5 M,Ci/ml. At the indicated times,
two samples were removed; one was chilled
immediately, and the RNA was extracted with
phenol. The other was treated with Miracil, 35
,ug/ml, and incubated at 37 C until 40 min post-
infection, when all the cultures were chilled, and
the RNA from each was extracted with phenol.
Each sample was assayed for infective viral RNA.
b Time of sampling and of Miracil addition in
minutes postinfection.
c The amount of infective RNA in the samples
taken at each time point is expressed as a per-
centage of the amount at 40 min in a culture not
treated with Miracil (relative infectivity at t). The
amount of infective RNA at 40 min in the cultures
treated with Miracil from t to 40 min is also ex-
pressed as a percentage of the amount in the
40-min untreated culture (relative infectivity at 40
min with Miracil present from t to 40 min).
TABLE 2. Effect of Miracil on synthesis oj
ribonuclease-resistant RNAa
Relative ribonuclease
Relative ribonuclease resistance at 40 min
tb resistance at t with AMiracil present|() from t to 40 min(%)
4 9.1 27.0
8 21.4 48.6
12 32.0 53.5
16 46.0 58.2
20 69.8 78.3
25 85.0 87.0
40 100 100
a The samples from the experiment described
in the legend to Table 1 were also treated with
ribonuclease to determine the amount of radio-
activity which had been incorporated into
ribonuclease-resistant material. The number of
ribonuclease-resistant counts in each sample is
expressed as a percentage (relative ribonuclease
resistance) of the number in a culture at 40 min
which had not been treated with Miracil.
I Time of sampling and of Miracil addition in
minutes postinfection.
completed.) Both samples were labeled with
3H-uracil from 10 to 30 min postinfection. An
uninfected culture was Miracil-treated and
labeled at the same time to determine which
bacterial RNA species were being synthesized
under these conditions. Figure 5 shows the sedi-
mentation pattern of the RNA from each culture.
Host RNA synthesis at this Miracil concentra-
tion is only 5 to 10% of the rate in untreated
cultures. Analysis of the RNA from the unin-
fected culture shows that 23, 16, and 4S all are
produced in reduced amounts in the presence
of the drug.
In the infected sample without Miracil, the
27S viral peak is distinguishable, and the position
of replicative intermediate molecules in the 16 to
25S region can be detected by their partial
resistance to ribonuclease but any other informa-
tion about viral RNA species is obscured by the
large amount of radioactivity in host RNA.
In Miracil, virus-specific RNA species are readily
distinguishable. Although the amount of 27S
and double-stranded RNA is reduced compared
to the untreated sample since Miracil was added
so early in infection, the phage-specific RNA
synthesized in the presence of the drug does not
differ from that produced in its absence, at least
with regard to sedimentation properties. (Due
to the difference in scale in Fig. 5b and c, there
appears to be no significant increase in the
amount of ribonuclease-resistant material in
the infected culture compared with the unin-
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fected one. The actual amount of ribonuclease-
27 S 23S 16S resistant radioactivity, however, is five times
25 higher in the infected Miracil-treated culture.)
(a) There is still some residual incorporation into
host 4S RNA and probably also into ribosomal
20 RNA, but the proportion of labeled bacterial
RNA is far less than in the absence of the drug.
Phage RNA synthetase production. The results.
above indicate that both viral and comple-
15- mentary strand synthesis can continue in Miradil-
treated, infected cells, but only to a limited
extent when the drug is added before 20 mmn of'
infection, and that the viral RNA species syn-
10 thesized in the presence of the drug appear
normal. These results would be explained if
Miracil inhibited viral RNA synthetase activity.
5 The strong similarity between the time course
of Miracil inhibition (Fig. 3) and the time course
of RNA synthetase production (Fig. 6) also0
~~~~~~~~~~~~suggests that Miracil might be aff-ecting the en-
x o~~5~zyme activity in some way.
.C0When a crude lysate was assayed for replicase
E 27S 23S 16S activity at 20 min postinfection, Miracil did not
inhibit triphosphate incorporation even at con-
u15 -~~~~~~(b centrations as high as 200 A.glml. The conditions
IT ~~~~~~~~~~~ofthe assay were as described above. Miracil is
soluble at the pH of the assay (7.2 to 7.4), and,
10 ~~~~~~~~although the Mg'+ concentration is approxi-
~~~~~~~~~~~matelyl0-1 m, it is unlikely that the presence of
this cation in the assay is preventing the in-
hibitory activity of Miracil since DNA-dependent
5 RNA polymerase activity was 98% inhibited by
less than 20 ysg of Miracil per ml in the presence
of similar Mg2+ concentrations (20). These
results suggest that the drug does not halt RNA
0 synthesis by interacting directly with either the
23S16S ~~~~enzyme or its template. However, since the source
3 - of enzyme and template was a whole cell lysate,(c)
~it is possible that the incorporation observed
2 - in vitro merely reflects the completion of viral
I ~~~~~~~~~andcomplementary strands initiated in vivoand does not include any reinitiation of synthe-
0
~~~~~~~~~~sis.Thus, although Miracil appears unable to0
~ t 2 0 affect the enzyme or template once synthesis has10 0 3
~~~~egn,we cannot determine for certain with this
FRACTIONNUMBER
~type of assay whether Miracil interferes with
FIG. 5. Sedimentation pattern of bacterial and viral
RNA synithesized in the presence of Miracil. E. coli__________ ____________
cells were growvn to 2 X 108/ml in TPG-c pluts uracil,
S jig/ml. A samnple was removed for the uninfected
cultuire, and the remainder was inifected withi MS2 at a sedimientationi. Centrifiugaition wvas at 300,000 X g
multiplicity of 3. At 8 miii postinfectioni, the inifected fior 2 hr in an SW65 rotor at 4 C. Onie half of each
portioni was split; Miracil, 35 jig/ml, was added to one gradienit fraction was precipitated directly. The other
half anid to the utninfected cultuire. Two minutes later, half was treated with riboniuclease before precipitationl
3H-uracil was added to all thtree cultures to a concen- anid coitiliting. *, Total 3H counts per minute; 0,
tration of 0.5 40Ciml. The cells were inicubated to 30 ribonzuclease-resistanit IH counts per miniute. a, In-
mmn postinfection and harvested, and the RNA was fected culture, no Miracil; b, infected culture in Mira-
extracted wvith phenol. Equal portions of thze three cil, 35 uig/ml; c, uninfected culture in Miracil, 35
RN/A prepara-ctionis were anialyzed by sutcrose gradient jig/ml (niote chanige of scale).
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enzyme-template binding or with initiation of
synthesis.
Infected cultures with and without Miracil
were assayed for synthetase activity at intervals
during infection to test the possibility that
the drug prevents formation of active enzyme
rather than inhibits its activity (Fig. 6). Very
little enzyme activity was present when Miracil
was added, but by 20 min postinfection the level
of activity in the Miracil-treated culture was
almost equal to that in the untreated culture.
What is striking is that the RNA synthetase
activity in the preparation from the Miracil-
treated culture drops off sharply after 20 min,
whereas that in the control without Miracil
remains constant. This is not due to selective
lysis of infected cells in the Miracil-treated cul-
ture and loss of the synthetase into the super-
natant fluid, since the cell count remained con-
stant. Thus it seems possible that the presence
of Miracil during production of the RNA syn-
thetase may cause some alteration in the activ-
ity of the enzyme.
DISCUSSION
Under certain growth conditions, Miracil D
at 35 to 40 ,ug/ml almost completely inhibits
c
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FIG. 6. Production of viral RNA synihetase in
Miracil. E. coli cells were grown to 4 X 108/ml in
TPG-c and infected with MS2 at a multiplicity of 2.
At 8 min postinfection, the culture was divided and
Miracil, 40 ,ug/ml, was added to one half. At various
limes, samples were removed from each culture,
ciilled rapidly, and lysed. Eaclh sample was assayed
for viral RNA syntlietase as described in the text.
The arrow indicates the time at which Miracil was
added. *, Micromoles of cytosine triphosphate in-
corporated per milligram of protein in crude enzyme
preparations from the culture without Miracil; 0,
from the culture with Miracil.
RNA synthesis in intact E. coli MRE 600 cells.
Suppression of DNA and protein synthesis is
not as great. Similar results were obtained by
Weinstein et al. (20) in a different E. coli strain.
In vitro the drug complexes with DNA (21) to
inhibit E. coli RNA polymerase activity and,
to a much lesser extent, DNA polymerase activ-
ity. Miracil also binds slightly to RNA, but,
since it does not inhibit amino acid incorpora-
tion in vitro with either natural or synthetic
messenger (20), its inhibitory effect on protein
synthesis in vivo is probably secondary, resulting
from depletion of cellular messenger RNA.
The inhibitory effect of Miracil varies widely
when cells are grown in different media. The
effect is unrelated to bacterial growth rate since
the drug works equally well in minimal and in
complex media. Nor are pH differences (in
the range 6.5 to 7.8) responsible for the variation.
The sensitivity of cells to Miracil is, however,
at least partly dependent on the ionic composi-
tion of the medium. It is interesting, with re-
gard to our observations on the effect of Ca2+
that the inhibitory effects of Miracil D are also
prevented by polyamines (20). The concentrations
of divalent cations, phosphates, and possibly
other salts as well appear to play a complex
role in determining cellular susceptibility to
Miracil probably by altering the permeability
characteristics of the cells.
Miracil appears to inhibit the MS2 infection
process at two different steps. When the drug is
added prior to infection, viral RNA penetration
is suppressed; however, this effect is easily
avoided by synchronizing the infection in chlor-
amphenicol before adding Miracil. The exact
nature of the second effect, which inhibits a
function required between 0 and 20 min of in-
fection, remains unclear. Although viral RNA
synthesis is reduced in the presence of Miracil,
neither double- nor single-stranded RNA syn-
thesis is specifically affected, and the viral RNA
species which are synthesized are the same as
those produced in the absence of the drug.
Especially notable is the absence of a large peak
of ribonuclease-resistant material at 6 to 1Os,
such as is found when MS2-infected cells are
treated with actinomycin D (9).
In Miracil-treated infected cultures (cf. Fig. 5),
there is a small peak of ribonuclease-resistant
RNA at 4 to 6S. A portion of this is probably
attributable to the partial ribonuclease resistance
of soluble RNA (16); however, the number of
ribonuclease-resistant counts at 4S in the in-
fected culture is increased several-fold over the
number in the uninfected culture; a small amount
of 6S material might be present in the leading
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edge of the 4S peak. Samples taken as late as 60
min after infection show no increase in the pro-
portion of this small ribonuclease-resistant RNA.
Since Miracil can bind slightly to RNA (20),
it may inhibit some step in the MS2 infection
process by binding to single- or double-stranded
viral RNA. According to the time course of in-
hibition, the drug interferes with an early stage of
infection and apparently does not affect the
messenger activity of the RNA or maturation
and assembly of the phage particles. Small
amounts of drug might be associated with the
viral RNA species and prevent either replicase
binding or activity, thereby disrupting RNA
replication. The fact that even very high con-
centrations of Miracil have no effect on triphos-
phate incorporation when the replicase is assayed
in vitro argues against this possibility. However,
since a cell lysate was the source of enzyme and
template, we can conclude only that Miracil
does not interact directly with either enzyme or
template to inhibit replicase activity; we cannot
conclude whether it interferes with enzyme bind-
ing or initiation.
Miracil appears to have a marked effect on the
activity of the viral RNA svnthetase produced
in its presence (Fig. 6). Since these enzyme assays
were also performed on whole cell lysates, sev-
eral variables (e.g., decreased endogenous tem-
plate concentration, variations in nuclease activ-
ity, etc.) might be responsible for the drop in
enzyme activity after 20 min in Miracil. It seems
im,probable that the loss in activity at later times
of infection results from the binding of drug to
template. If this were the case, inhibition should
also be observed at earlier times, when the ratio
of drug to viral RNA species should be much
higher. Although these data are not inconsistent
with the possibility that Miracil somehe.w alters
the viral RNA synthetase, much more detailed
studies on the enzyme synthesized in the drug's
presence would be required before it could be
cited as the target of Miracil action.
It is interesting to note that addition of two
other drugs which inhibit bacterial RNA syn-
thesis-actinomycin D and rifampin-during
the first few minutes after infection with RNA
phage also inhibits the progeny phage yield,
presumably because some host component or
components required for infection are not being
synthesized in their presence (1, 7, 9). Prime
candidates for such components would be host
factors similar to those which are required for
normal activity of the Q3 RNA synthetase (6).
The mode of action of Miracil might be similar
to that of the other two drugs. Indeed, if host
factors required for the viral replicase were not
synthesized in sufficient quantities or were ab-
normal in the presence of Miracil, this would
explain why the enzyme which is made is un-
stable.
Despite the fact that Miracil has an inhibitory
effect on the MS2 infection process, it is a useful
tool for suppression of host RNA and protein
synthesis during studies of RNA phage replica-
tion (3). Virus-specific functions apparently
are unaffected when the drug is added later than
20 min postinfection. Addition before this time
reduces the amount of phage-specific RNA syn-
thesis and inhibits progeny phage production,
but these effects are reversible, and the virus-
specific species which are made-almost cer-
tainly the RNA and probably the protein-do
not differ significantly from those made in the
absence of the drug.
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